1. Pink Sheet
  2. >>Compliance
  3. >>Marketing & Advertising

After DTC Rule Tossed Out In Court, Attention Turns (Again) To Congress

 
• By Sue Sutter

HHS lacks authority to require drug price disclosures in TV ads, judge rules. Even if legislation were to explicitly give the Trump Administration such authority, First Amendment issues would still linger.

courtroom-gavel
A federal judge ruled against the Trump Administration's plan to require disclosure of prices in DTC ads. • Source: Shutterstock

A US federal judge delivered a succinct message in striking down a Trump Administration rule requiring disclosure of drug prices in direct-to-consumer television ads – Congress knows how to legislate on drug advertising but has not chosen to do so in the context of pricing.

In an 8 July opinion, US Judge Amit Mehta ruled that the Department of Health and Human Services lacks...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Marketing & Advertising

More from Compliance

UK MHRA: Bacteriophage Developers Wanted ‘More Clarity’ On UK Framework

 
• By Eliza Slawther

Julian Beach, interim executive director of healthcare quality and access at the UK drug regulator, the MHRA, tells the Pink Sheet how the agency is responding to increased efforts to develop bacteriophage therapies.

Novo, Lilly Ad Challenges Cause Discontinued Claims For Compounded GLP-1s

 
• By Sue Sutter

Two pharmacies, a medical spa and a telehealth company voluntarily removed efficacy, safety and quality claims for compounded GLP-1 products after innovator companies filed challenges with the National Advertising Division.

EU Emergency Response Authority Needs Bigger Budget To Address Health Threats, Says Industry

 
• By Eliza Slawther

The EU must renew the mandate of its Health Emergency Response Authority to support medicine stockpiles and enable agile manufacturing to combat antimicrobial resistance and chemical, biological, radiological and nuclear threats, says trade organization EUCOPE.